Literature DB >> 33463320

Long-Term Detection of Oncogenic MicroRNA in Living Human Cancer Cells by Gold@ Polydopamine-Shell Nanoprobe.

Wai Ki Wong1, Siu Hong Dexter Wong1, Liming Bian1,2,3.   

Abstract

Oncogenic microRNAs (miRNA), for example, miR-155, are key tumor biomarkers in cancer cells that drive tumorigenesis, and the miRNA profile signature can predict cancer development and aggressiveness. Hence, timely detection of oncogenic miRNA in living cells is highly attractive to the diagnosis of cancer at an early stage. Herein, we report a highly sequence-specific gold@polydopamine-based nanoprobe for long-term detection of miRNA in human cancer cell lines in vitro. A single administration of the nanoprobe enables continuous detection of the miR-155 expression level in living cancer cells for up to 5 days. We believe that our nanoprobe is highly promising for both oncology research and translational applications.

Entities:  

Keywords:  cancer cellular uptake; fluorescence quenching; gold nanoprobes; long-term real-time imaging; oncogenic miRNA

Mesh:

Substances:

Year:  2020        PMID: 33463320     DOI: 10.1021/acsbiomaterials.0c00633

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  3 in total

Review 1.  The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy.

Authors:  Wai Ki Wong; Bohan Yin; Ching Ying Katherine Lam; Yingying Huang; Jiaxiang Yan; Zhiwu Tan; Siu Hong Dexter Wong
Journal:  Front Cell Dev Biol       Date:  2022-01-11

Review 2.  Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research-A Review.

Authors:  Iasmina Marcovici; Dorina Coricovac; Iulia Pinzaru; Ioana Gabriela Macasoi; Roxana Popescu; Raul Chioibas; Istvan Zupko; Cristina Adriana Dehelean
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

3.  Two-step formulation of magnetic nanoprobes for microRNA capture.

Authors:  Iveta Vilímová; Igor Chourpa; Stéphanie David; Martin Soucé; Katel Hervé-Aubert
Journal:  RSC Adv       Date:  2022-03-02       Impact factor: 3.361

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.